[Controlled clinical study of a topic associating nopoxamine with diethylamine salicylate (Algésal suractivé) in physical medicine and rehabilitation (author's transl)].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D010919:Placebos; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000008:administration & dosage*; D013729:Terpenes / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D010919:Placebos; D012459:Salicylates; D013729:Terpenes; C026192:diethylamine salicylate, myrtecaine drug combination; C026191:diethylamine salicylate
Etude clinique contrôlée d'un topique associant la nopoxamine au salicylate de diéthylamine (Algésal suractivé) en médecine physique et réhabilitation.